ACE2 activator and angiotensin II receptor antagonist

This page covers all ACE2 activator and angiotensin II receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ACE2 and AT1R.

Targets

ACE2 and AT1R

Phase 3 pipeline (1)

• Sacubitril / Valsartan Oral Tablet [Entresto] · University Hospital, Grenoble · Cardiovascular
  Sacubitril is an angiotensin-converting enzyme 2 (ACE2) activator, while valsartan is an angiotensin II receptor antagonist.

Patent intelligence

• ace2 activator and angiotensin ii receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates